• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过比较分子场分析和分子模拟预测的二肽基肽酶IV活性位点模型。

A model of the active site of dipeptidyl peptidase IV predicted by comparative molecular field analysis and molecular modelling simulations.

作者信息

Brandt W, Lehmann T, Thondorf I, Born I, Schutkowski M, Rahfeld J U, Neubert K, Barth A

机构信息

Biochemistry/Biotechnology Department, Martin-Luther-University of Halle-Wittenberg, Germany.

出版信息

Int J Pept Protein Res. 1995 Dec;46(6):494-507. doi: 10.1111/j.1399-3011.1995.tb01605.x.

DOI:10.1111/j.1399-3011.1995.tb01605.x
PMID:8748710
Abstract

A molecular model of the active site of the serine protease dipeptidyl peptidase IV (DPP IV or CD26) has been developed on the basis of comparative molecular field analysis (CoMFA) of competitive inhibitors and by force field calculations. By application of CoMFA experimentally obtained inhibition constants Ki have been successfully predicted. The resulting steric and electrostatic coefficients of CoMFA were used for the development of the molecular model. The main assumptions of the model are the recognition of substrates or inhibitors by the side chains of a tyrosine (S1-position) and a tryptophan residue (S2-position). The model helps us to understand a multitude of experimental data regarding the substrate specificity of this enzyme as well as results obtained by genetic engineering experiments by other authors. General conclusions concerning a new family of serine proteases are drawn and discussed.

摘要

基于竞争性抑制剂的比较分子场分析(CoMFA)并通过力场计算力场计算,已构建了丝氨酸蛋白酶二肽基肽酶IV(DPP IV或CD26)活性位点的分子模型。通过应用CoMFA,已成功预测了实验获得的抑制常数Ki。CoMFA所得的空间和静电系数被用于分子模型的构建。该模型的主要假设是酪氨酸(S1位)和色氨酸残基(S2位)的侧链对底物或抑制剂的识别。该模型有助于我们理解关于该酶底物特异性的大量实验数据,以及其他作者通过基因工程实验获得的结果。得出并讨论了关于丝氨酸蛋白酶新家族的一般性结论。

相似文献

1
A model of the active site of dipeptidyl peptidase IV predicted by comparative molecular field analysis and molecular modelling simulations.通过比较分子场分析和分子模拟预测的二肽基肽酶IV活性位点模型。
Int J Pept Protein Res. 1995 Dec;46(6):494-507. doi: 10.1111/j.1399-3011.1995.tb01605.x.
2
CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements.作为二肽基肽酶 IV 抑制剂的各种吡咯烷类似物的 CoMFA 和 CoMSIA:活性位点要求。
Mol Divers. 2011 May;15(2):457-66. doi: 10.1007/s11030-010-9267-0. Epub 2010 Aug 25.
3
Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.二肽基肽酶IV-β——进一步的特性鉴定及与CD26二肽基肽酶IV活性的比较
Eur J Biochem. 1998 Sep 1;256(2):369-78. doi: 10.1046/j.1432-1327.1998.2560369.x.
4
In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.通过计算机模拟方法预测乳蛋白衍生肽作为二肽基肽酶IV(DPP-IV)抑制剂的潜力。
Peptides. 2014 Jul;57:43-51. doi: 10.1016/j.peptides.2014.04.018. Epub 2014 May 2.
5
A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.新型二肽基肽酶 IV 抑制剂在活性部位结合模式的比较研究。
Biochem Biophys Res Commun. 2013 May 3;434(2):191-6. doi: 10.1016/j.bbrc.2013.03.010. Epub 2013 Mar 15.
6
3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.基于对接比对的二肽基肽酶IV抑制剂的3D-QSAR研究
J Mol Model. 2007 Oct;13(10):1047-71. doi: 10.1007/s00894-007-0227-2. Epub 2007 Aug 4.
7
Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor.二肽基肽酶IV与其抑制剂的共结构综合分析。
BMC Struct Biol. 2016 Aug 5;16:11. doi: 10.1186/s12900-016-0062-8.
8
Development of a tertiary-structure model of the C-terminal domain of DPP IV.二肽基肽酶IV C末端结构域三级结构模型的构建
Adv Exp Med Biol. 2000;477:97-101. doi: 10.1007/0-306-46826-3_9.
9
Molecular recognition of ligands in dipeptidyl peptidase IV.
Curr Top Med Chem. 2007;7(6):609-19. doi: 10.2174/156802607780091064.
10
Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV.酪氨酸547是二肽基肽酶IV催化机制的重要组成部分。
J Biol Chem. 2004 Aug 13;279(33):34691-7. doi: 10.1074/jbc.M405400200. Epub 2004 Jun 2.

引用本文的文献

1
Computational Modeling of the Interactions between DPP IV and Hemorphins.二肽基肽酶IV与血啡肽相互作用的计算模型
Int J Mol Sci. 2024 Mar 6;25(5):3059. doi: 10.3390/ijms25053059.
2
M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.M24B 氨肽酶抑制剂选择性激活 CARD8 炎性小体。
Nat Chem Biol. 2022 May;18(5):565-574. doi: 10.1038/s41589-021-00964-7. Epub 2022 Feb 14.
3
Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.β-苯丙氨酸衍生物作为二肽基肽酶 IV 抑制剂的分子对接和 3D-QSAR 研究。
J Mol Model. 2010 Jul;16(7):1239-49. doi: 10.1007/s00894-009-0637-4. Epub 2010 Jan 13.
4
3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.基于对接比对的二肽基肽酶IV抑制剂的3D-QSAR研究
J Mol Model. 2007 Oct;13(10):1047-71. doi: 10.1007/s00894-007-0227-2. Epub 2007 Aug 4.
5
Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV.牙龈卟啉单胞菌脯氨酸特异性肽酶新家族:丝氨酸二肽基肽酶的纯化与特性分析,其为哺乳动物脯氨酰二肽基肽酶IV的结构和功能同源物
Infect Immun. 2000 Mar;68(3):1176-82. doi: 10.1128/IAI.68.3.1176-1182.2000.
6
Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.正常和肿瘤性人类T淋巴细胞群体中二肽基肽酶IV(CD26)功能的多色细胞酶学评估
Clin Diagn Lab Immunol. 1998 May;5(3):362-8. doi: 10.1128/CDLI.5.3.362-368.1998.